The performance of risk stratification tools such as the Mehran risk score and MACD ratio for predicting contrast-induced acute kidney injury in TAVR cohorts is less well defined.
Do the Mehran risk score and contrast volume:MACD ratio predict contrast-induced acute kidney injury in patients undergoing TAVR?
Contrast-induced nephropathy (CIN) is the third most common cause of hospital acquired renal failure. Risk stratification tools, such as the Mehran risk score and the contrast volume: maximum allowable contrast dose (MACD) ratio, are used to predict contrast-induced acute kidney injury (CI-AKI) in patients undergoing percutaneous coronary intervention. Their performance in transcatheter aortic valve replacement (TAVR) cohorts is less well defined.
Uraizee et al. (Wed,) conducted a other in Contrast-induced acute kidney injury in transcatheter aortic valve replacement (TAVR). Mehran risk score and MACD ratio was evaluated on Contrast-induced acute kidney injury (CI-AKI). The performance of risk stratification tools such as the Mehran risk score and MACD ratio for predicting contrast-induced acute kidney injury in TAVR cohorts is less well defined.